Vaccine equity: Past, present, and future
- PMID: 35474741
- PMCID: PMC8831140
- DOI: 10.1016/j.xcrm.2022.100551
Vaccine equity: Past, present, and future
Abstract
The term "vaccine equity" primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward "health equity," and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.
© 2022 The Author(s).
Conflict of interest statement
R.v.d.G., J.L.B., and A.Y.B. declare no competing interests.
Figures
References
-
- UNDP Global Dashboard for Vaccine Equity - UNDP Data Futures Platform. https://data.undp.org/vaccine-equity/ Accessed 2022 Feb 1.
-
- GAVI COVAX explained | Gavi, the Vaccine Alliance. https://www.gavi.org/vaccineswork/covax-explained Accessed 2022 Feb 1.
-
- World Health Organisation Achieving 70% COVID-19 Immunization Coverage by Mid-2022. https://www.who.int/news/item/23-12-2021-achieving-70-covid-19-immunizat... Accessed 2022 Feb 1.
-
- Perehudoff K., Thoen E., Boulet P. Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too. BMJ Global Health. 2021;6:e005518. https://gh.bmj.com/content/6/4/e005518 - PMC - PubMed
-
- Médecins Sans Frontières Access Campaign Sharing mRNA vaccine technologies to save lives | Médecins Sans Frontières Access Campaign. https://msfaccess.org/sharing-mrna-vaccine-technologies-save-lives Accessed 2022 Feb 1.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
